Randomised clinical trial: a liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome - a 12 week double-blind study

2014142 citationsJournal Article

Authors

Ingvar Bjarnason · King's College Hospital

Abstract

The multi-strain probiotic was associated with a statistically significant improvement in overall symptom severity in patients with IBS, and was well tolerated. These results suggest this probiotic confers benefit in IBS and deserves further investigation (ISRCTN identifier: 77512412).

Topics & Keywords

Gastrointestinal motility and disorders Infant Health and Development Diet and metabolism studies

Publication Details

Published in: Alimentary Pharmacology & Therapeutics

Volume 40, Issue 1, pp. 51-62

DOI: 10.1111/apt.12787

Field-Weighted Citation Impact: 7.17

Command Palette

Randomised clinical trial: a liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome - a 12 week double-blind study

Authors

Abstract

Topics & Keywords

Publication Details